RBM11 and ovarian carcinoma: Therefore, we performed a transwell assay to evaluate the role of RBM11 in ovarian cancer invasion, as shown in Figure 3(a); the number of invaded OVCAR-3 and A2780 cells expressing RBM11 shRNA is remarkable less than that expressing control (ctrl) shRNA.